99mTc-MIBI uptake in a primitive leptomeningeal melanoma

European Journal of Dermatology

Volumn 8, Issue 3, 1998, Pages 169-172

  Soler, Claude ^a   Beauchesne, Patrick ^a   Moncet, Michèle ^b   Perrot, Jean Luc ^c   Mosnier, Jean François ^a   Fotso, Marie Jeannette ^a   Antoine, Jean Christophe ^a   Brunon, Jacques ^a   Dubois, Francis ^a  

^a SERVICE DE NEUROLOGIE   (France)

^b Centre Hospitalier de Vienne   (France)

^c HÔPITAL NORD   (France)

Author keywords

99mTc MIBI; Primitive leptomeningeal melanoma

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BRAIN TUMOR; CANCER INVASION; CASE REPORT; DIAGNOSTIC IMAGING; ELECTRIC POTENTIAL; FEMALE; HEART PERFUSION; HUMAN; IMAGE ANALYSIS; LEPTOMENINX; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; MENINGIOMA; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MELANOMA; MENINGEAL NEOPLASMS; MIDDLE AGED; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0031593682     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Yoshii Y, Satou M, Yamamoto T, et al. The role of thallium-201 single photon emission tomography in the investigation and characterization of brain tumors in man and their response to treatment. Eur J of Nucl Med 1993; 20: 39.
2. Vertosick FT Jr, Selker RG, Stanley J, et al. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 1994; 34: 396.
3. Aktolun C, Bayhan H, Kir M, et al. Clinical experience with Tc 99m-MIBI imaging in patients with malignant tumors. Preliminary results and comparison with thallium-201. Clin Nucl Med 1992; 17: 171.
4. Balon HR, Fink-Bennett D, Stoffer SS. Technetium-99m-MIBI uptake by recurrent Hürthle cell carcinoma of the thyroid. J Nucl Med 1992; 33: 1393.
5. Ziegels P, Nocaudie M, Huglo D, et al. Comparison of technetium-99m-methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas. Eur J of Nucl Med 1995; 22: 126.
6. Matsui R, Komori T, Narabayashi I, et al. Tc 99m-MIBI uptake by malignant lymphoma and slow washout. Clin Nucl Med 1995; 20: 352.
7. Lu G, Shih WJ, Huang HY, et al. 99m Tc-MIBI mammoscintigraphy of breast masses: early and delayed imaging. Nucl Med Comm 1195; 16: 150.
8. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m-MIBI. Eur J of Nucl Med 1994; 21: 358.
9. O'Tuama LA, Treves ST, Larar JN, et al. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: a within-subject comparison. J of Nucl Med 1993; 34 (7): 1045.
10. O'Tuama LA, Packard AB, Treves ST, et al. SPECT imaging of pediatric brain tumor with hexakis (memoxyisobutylisonitrile) technetium (I). J of Nucl Med 1990; 31 (12): 2040.
11. Bagni B, Penna L, Tamarozzi R, et al. SPECT imaging of intracranial tumors with 99m Tc-MIBI. Nucl Med Comm 1995; 16: 258.
12. Kaplan WD, Takvorian RA, Kim KT, et al. Thallium-201 brain tumor imaging. A comparison study with pathologic correlation. J of Nucl Med 1987; 28: 47.
13. Chen LB. Mitochondrial membrane potential in living cell. Ann Rev Cell Biol 1988; 4: 155.
14. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, et al. Uptake of the cation hexakis (2 metoxyisobutylisonitrile)-technetium 99m by human carcinoma cell line in vitro. Cancer Res 1990; 50: 2198.
15. 99mTc-MIBI in heart cell: calculation of mitochondrial membrane potential. Am J Physiol 1993; 265 (Cell Physiol. 34): c178-c87.
16. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2 metoxyisoburylisonitrile) technetium (I): mitochondrial and plasma membrane potential dependence. Circulation 1990; 82: 1826.
17. O'Doherty MJ, Kettle AG, Wells P. Parathyroid imaging with technetium-99m-MIBI: preoperative localization and tissue uptake studies. J of Nucl Med 1992; 33: 313.
18. Aichner F, Schuler G. Primary leptomeningeal melanoma diagnosis by ultrastructural cytology of cerebrospinal fluid and cranial computed tomography. Cancer 1982; 50: 1751-6.
19. Crispe DE, Thompson JA. Primary malignant melanomatosis of the meninges. Clinical course and computed tomographic findings in a young child. Arch Neurol 1981; 38: 528.
20. Stephenson WM, Merlis AL. Computed tomography of primary melanoma of the leptomeninges: case reports. J Comput Assist Tomogr 1985; 9: 337-42.
21. 99mTc-MIBI SPECT during follow-up of malignant melanoma in 17 patients. Eur J Dermatol 1996; 6: 505-8.
22. Soler C, Perrot JL, Thiffet O, et al. The role of technetium-99m sestamibi single photon emission tomography in the follow-up of malignant melanoma and the detection of lymph node metastases. Eur J Nucl Med 1998; 24: 1522-5.
23. 123I-iodoamphetamine. Nucl Med Comm 1996; 17: 153-9.
24. Hoefnagel CA, Rankin EM, Valdes-Olmos RA, et al. Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide. Eur J Nucl Med 1994; 21: 587.
25. Rodot S, Darcourt J, Bussiere F, et al. A radiolabelled iodobenzamide for malignant melanoma staging. Melanoma Res 1994; 4: 301 (7): 557-9.
26. Miyazaki T, Ohnishi T, Hoshi H, et al. TI 201 uptake in an intracranial primary malignant melanoma. Clin Nucl Med 1996; 21 (7): 572.
27. Rettenbacher L, Koller J, Galvan G. Detection of cutaneous metastatic melanoma with TI-201 scintigraphy. Clin Nucl Med 1996; 21 (1): 67.
28. 99mTc-MIBI. Clin Nuc/ Med 1996: 21.
29. Park HM. Demonstration of metastatic melanoma by Tc-99m sestamibi imaging. Clin Nucl Med 1996; 21 (7): 63-4.